87 related articles for article (PubMed ID: 12114402)
1. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
Moulton HM; Yoshihara PH; Mason DH; Iversen PL; Triozzi PL
Clin Cancer Res; 2002 Jul; 8(7):2044-51. PubMed ID: 12114402
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells.
Jiang C; Jiang Y; Huang Z; Shen W; Wang J; Shen Q
Cancer Immunol Immunother; 2010 Dec; 59(12):1771-9. PubMed ID: 20809357
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers.
Toubaji A; Achtar M; Provenzano M; Herrin VE; Behrens R; Hamilton M; Bernstein S; Venzon D; Gause B; Marincola F; Khleif SN
Cancer Immunol Immunother; 2008 Sep; 57(9):1413-20. PubMed ID: 18297281
[TBL] [Abstract][Full Text] [Related]
4. Effects of antibodies to choriogonadotropin in malignant growth. II. Solid transplantable rat tumors.
Kellen JA; Kolin A; Mirakian A; Acevedo HF
Cancer Immunol Immunother; 1982; 13(1):2-4. PubMed ID: 6297711
[TBL] [Abstract][Full Text] [Related]
5. Sotatercept in patients with osteolytic lesions of multiple myeloma.
Abdulkadyrov KM; Salogub GN; Khuazheva NK; Sherman ML; Laadem A; Barger R; Knight R; Srinivasan S; Terpos E
Br J Haematol; 2014 Jun; 165(6):814-23. PubMed ID: 24650009
[TBL] [Abstract][Full Text] [Related]
6. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.
Bailey CJ; Gross JL; Pieters A; Bastien A; List JF
Lancet; 2010 Jun; 375(9733):2223-33. PubMed ID: 20609968
[TBL] [Abstract][Full Text] [Related]
7. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer.
Hofheinz RD; al-Batran SE; Hartmann F; Hartung G; Jäger D; Renner C; Tanswell P; Kunz U; Amelsberg A; Kuthan H; Stehle G
Onkologie; 2003 Feb; 26(1):44-8. PubMed ID: 12624517
[TBL] [Abstract][Full Text] [Related]
8. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.
Punt CJ; Nagy A; Douillard JY; Figer A; Skovsgaard T; Monson J; Barone C; Fountzilas G; Riess H; Moylan E; Jones D; Dethling J; Colman J; Coward L; MacGregor S
Lancet; 2002 Aug; 360(9334):671-7. PubMed ID: 12241873
[TBL] [Abstract][Full Text] [Related]
9. Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study.
Cripps MC; Figueredo AT; Oza AM; Taylor MJ; Fields AL; Holmlund JT; McIntosh LW; Geary RS; Eisenhauer EA
Clin Cancer Res; 2002 Jul; 8(7):2188-92. PubMed ID: 12114419
[TBL] [Abstract][Full Text] [Related]
10. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip.
Suryavanshi P; Bodas D
Nanotheranostics; 2024; 8(3):380-400. PubMed ID: 38751938
[TBL] [Abstract][Full Text] [Related]
11. Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer.
Martinis E; Ricci C; Trevisan C; Tomadini G; Tonon S
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514155
[TBL] [Abstract][Full Text] [Related]
12. Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors.
Sarkar M; Sharma H; Singh P; Ranu R; Sharma RD; Agrawal U; Pal R
iScience; 2022 Jul; 25(7):104527. PubMed ID: 35754725
[TBL] [Abstract][Full Text] [Related]
13. Unconventional Actions of Glycoprotein Hormone Subunits: A Comprehensive Review.
Querat B
Front Endocrinol (Lausanne); 2021; 12():731966. PubMed ID: 34671318
[TBL] [Abstract][Full Text] [Related]
14. Gold(III) Aryl Complexes as Reagents for Constructing Hybrid Peptide-Based Assemblies via Cysteine
Stauber JM; Rheingold AL; Spokoyny AM
Inorg Chem; 2021 Apr; 60(7):5054-5062. PubMed ID: 33739101
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial Immunotherapies for Metastatic Colorectal Cancer.
Janssen E; Subtil B; de la Jara Ortiz F; Verheul HMW; Tauriello DVF
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664619
[TBL] [Abstract][Full Text] [Related]
16. Human Chorionic Gonadotrophin: New Pleiotropic Functions for an "Old" Hormone During Pregnancy.
Gridelet V; Perrier d'Hauterive S; Polese B; Foidart JM; Nisolle M; Geenen V
Front Immunol; 2020; 11():343. PubMed ID: 32231662
[TBL] [Abstract][Full Text] [Related]
17. A case report of paraneoplastic syndrome in β-hCG-secreting duodenal adenocarcinoma.
Kang S; Zaidi AJ; Shokouh-Amiri M; Wiley E; Venepalli NK
J Gastrointest Oncol; 2019 Dec; 10(6):1151-1156. PubMed ID: 31949933
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer.
Rawla P; Barsouk A; Hadjinicolaou AV; Barsouk A
Med Sci (Basel); 2019 Jul; 7(8):. PubMed ID: 31366129
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Gonadotropins Activity by Antibodies.
Kara E; Dupuy L; Bouillon C; Casteret S; Maurel MC
Front Endocrinol (Lausanne); 2019; 10():15. PubMed ID: 30833928
[TBL] [Abstract][Full Text] [Related]
20. The transgenic expression of the β-subunit of human chorionic gonadotropin influences the growth of implanted tumor cells.
Singh P; Sarkar M; Agrawal U; Huhtaniemi I; Pal R
Oncotarget; 2018 Oct; 9(78):34670-34680. PubMed ID: 30410667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
